United States of America
Price range: $90.00 through $740.00
The term “GLP3” highlights its triple-receptor mechanism, distinguishing it from older drugs: semaglutide (GLP-1 single agonist) and tirzepatide (GLP-1/GIP dual agonist), drsobo.com.
GLP3 works as a triple agonist, activating:
GLP3 is primarily being developed for weight management and is NOT FDA APPROVED
Common side effects are similar to other GLP-1-based drugs, mainly gastrointestinal issues such as nausea, vomiting, and diarrhea GoodRx. Rapid weight loss may also carry risks like kidney issues, bone fractures, or muscle loss Diabetes. It is still under investigation, and long-term safety data are limited.
GLP3 is a triple-agonist weight-loss medication targeting GLP-1, GIP, and glucagon receptors. Its main use is for significant weight reduction, with additional potential benefits for metabolic health. It is NOT FDA-approved
Reviews
There are no reviews yet.